How Much Did Paratus Sciences Raise?
Funding & Key Investors

Paratus Sciences has secured significant enterprise-level funding, with its total capital raised standing at $100M. The company recently announced a major strategic investment of $100M, underscoring its progress and market potential in the biotechnology sector. This latest financing round follows a series of strategic capital injections aimed at propelling the company's growth and innovation.

What is Paratus Sciences?

Paratus Sciences
Business ServicesResearch & Development

Paratus Sciences, based in New York, New York, is a biotechnology firm dedicated to advancing animal studies. The company's focus on this critical area of research positions it within a vital segment of the life sciences industry. Its operations are geared towards developing novel solutions and insights through rigorous scientific investigation, aiming to contribute to advancements in veterinary medicine and related fields. The recent influx of capital suggests a strong validation of its scientific approach and commercial strategy.

How much funding has Paratus Sciences raised?

Paratus Sciences has raised a total of $100M across 1 funding round:

2023

Series A

$100M

Series A (2023): $100M with participation from Polaris Partners, ClavystBio, and ARCH VENTURE PARTNERS

Key Investors in Paratus Sciences

Polaris Partners

Polaris Partners is a venture capital firm specializing in backing transformational companies in the biotech and healthcare sectors, known for their deep engagement with entrepreneurs to foster innovation and growth.

ClavystBio

ClavystBio is an entity participating in the recent funding round, contributing to the strategic capital injection for Paratus Sciences.

ARCH VENTURE PARTNERS

ARCH Venture Partners is a leading early-stage venture capital firm focused on life sciences and advanced technology, often co-founding startups to commercialize scientific innovations.

What's next for Paratus Sciences?

With the recent major strategic investment, Paratus Sciences is poised for an accelerated phase of development and expansion. The substantial capital infusion, totaling $100M, indicates a strong investor confidence in the company's long-term vision and its capacity to execute its strategic objectives. This funding will likely be instrumental in scaling operations, advancing research pipelines, and potentially exploring new market opportunities. The company's trajectory suggests a move towards further solidifying its position as a key player in the biotechnology landscape, particularly within animal health research.

See full Paratus Sciences company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesResearch & DevelopmentConsumer ServicesRepair Services
Business ServicesSoftware Testing
Accounting for Legal PracticesBusiness Services
Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding Paratus Sciences Financial Insights

What are the most recent funding rounds that Paratus Sciences has completed, and what were the funding rounds?
Paratus Sciences has recently completed 1 funding rounds: Series A on Feb 27, 2023.
What is the total amount of funding Paratus Sciences has raised to date?
Paratus Sciences has raised a total of $100M in funding to date.
How many funding rounds has Paratus Sciences completed?
Paratus Sciences has completed 1 funding rounds.
How much funding did Paratus Sciences raise in its most recent funding round?
Paratus Sciences raised $100M in its most recent funding round.
Who are the lead investors in Paratus Sciences's latest funding round?
The lead investor in Paratus Sciences's latest funding round was Polaris Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Paratus Sciences's history?
The largest funding round in Paratus Sciences's history was $100M.
See more information about Paratus Sciences